Apremilast
English name: Apremilast
CAS: 608141-41-9
Purity: 99%
Molecular formula: C22H24N2O7S
Molecular weight: 460.5
EINECS number: 807-237-6
CAS: 608141-41-9
Purity: 99%
Molecular formula: C22H24N2O7S
Molecular weight: 460.5
EINECS number: 807-237-6
C255
Quantity
Apremilast is a phosphodiesterase 4 inhibitor primarily used to treat psoriasis and arthritis. Its main functions and applications include:
1. Anti-inflammatory effect: Apremilast can reduce the release of inflammatory mediators by inhibiting the activity of phosphodiesterase 4, thereby reducing inflammatory reactions and reducing inflammatory symptoms of skin and joints.
2. Immunomodulatory effect: Apremilast can regulate the function of the immune system, reduce the immune system's attack on self-tissue, thereby alleviating symptoms caused by autoimmune diseases.
3. Indications: Apremilast is mainly used to treat adult patients with moderate to severe psoriasis and arthritis, including psoriatic arthritis and rheumatoid arthritis.
2. Immunomodulatory effect: Apremilast can regulate the function of the immune system, reduce the immune system's attack on self-tissue, thereby alleviating symptoms caused by autoimmune diseases.
3. Indications: Apremilast is mainly used to treat adult patients with moderate to severe psoriasis and arthritis, including psoriatic arthritis and rheumatoid arthritis.
Apremilast is widely used in the pharmaceutical field.
